ArticleJCO precision oncology2025

Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United States.

James R Janopaul-Naylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.